foxo4-dri senolytic peptide mechanism UK | Research Buy FOXO4-DRI (Proxofim) - Senolytic
Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity.
Pay in 4 interest-free payments of $6.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




